Perez S, Gooz M, Maldonado E
Cells. 2024; 13(21.
PMID: 39513896
PMC: 11545457.
DOI: 10.3390/cells13211789.
Chu F, Tong K, Gu X, Bao M, Chen Y, Wang B
Oncol Res. 2024; 32(10):1661-1671.
PMID: 39308523
PMC: 11413814.
DOI: 10.32604/or.2024.048287.
Urrutia A, Mesa-Ciller C, Guajardo-Grence A, Alkan H, Soro-Arnaiz I, Vandekeere A
Cell Rep. 2024; 43(4):114103.
PMID: 38607920
PMC: 11063627.
DOI: 10.1016/j.celrep.2024.114103.
Wu K, Gong W, Hu J, Duan Y, Ke H, Chen L
Exp Ther Med. 2024; 27(5):218.
PMID: 38590564
PMC: 11000443.
DOI: 10.3892/etm.2024.12506.
Shi L, Guo M, Shi C, Gao G, Xu X, Zhang C
J Cancer Res Clin Oncol. 2024; 150(3):142.
PMID: 38503944
PMC: 10951046.
DOI: 10.1007/s00432-024-05666-w.
Metabolism of asparagine in the physiological state and cancer.
Yuan Q, Yin L, He J, Zeng Q, Liang Y, Shen Y
Cell Commun Signal. 2024; 22(1):163.
PMID: 38448969
PMC: 10916255.
DOI: 10.1186/s12964-024-01540-x.
Glutaminase inhibition as potential cancer therapeutics: current status and future applications.
Cyriac R, Lee K
J Enzyme Inhib Med Chem. 2023; 39(1):2290911.
PMID: 38078371
PMC: 11721875.
DOI: 10.1080/14756366.2023.2290911.
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells.
Linder S, Bernasocchi T, Martinez-Pastor B, Sullivan K, Galbraith M, Lewis C
Nat Metab. 2023; 5(12):2131-2147.
PMID: 37957387
PMC: 11639397.
DOI: 10.1038/s42255-023-00919-3.
Glutamine metabolism in tumor metastasis: Genes, mechanisms and the therapeutic targets.
Zhong X, He Z, Yin L, Fan Y, Tong Y, Kang Y
Heliyon. 2023; 9(10):e20656.
PMID: 37829798
PMC: 10565784.
DOI: 10.1016/j.heliyon.2023.e20656.
Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer.
Huang R, Wang H, Hong J, Wu J, Huang O, He J
Front Immunol. 2023; 14:1251643.
PMID: 37731509
PMC: 10507177.
DOI: 10.3389/fimmu.2023.1251643.
Spatial metabolomics in head and neck tumors: a review.
Zheng Y, Lin C, Chu Y, Gu S, Deng H, Shen Z
Front Oncol. 2023; 13:1213273.
PMID: 37519782
PMC: 10374363.
DOI: 10.3389/fonc.2023.1213273.
De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence.
Yang C, Zhao Y, Wang L, Guo Z, Ma L, Yang R
Nat Cell Biol. 2023; 25(6):836-847.
PMID: 37291265
DOI: 10.1038/s41556-023-01146-4.
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia.
Xiao Y, Hu B, Guo Y, Zhang D, Zhao Y, Chen Y
Curr Treat Options Oncol. 2023; 24(8):1021-1035.
PMID: 37249801
PMC: 10356674.
DOI: 10.1007/s11864-023-01104-0.
Amino acid metabolism regulated by lncRNAs: the propellant behind cancer metabolic reprogramming.
Hu Q, Li Y, Li D, Yuan Y, Wang K, Yao L
Cell Commun Signal. 2023; 21(1):87.
PMID: 37127605
PMC: 10152737.
DOI: 10.1186/s12964-023-01116-1.
Engineering At-Home Dilution and Filtration Methods to Enable Paper-Based Colorimetric Biosensing in Human Blood with Cell-Free Protein Synthesis.
Free T, Tucker R, Simonson K, Smith S, Lindgren C, Pitt W
Biosensors (Basel). 2023; 13(1).
PMID: 36671942
PMC: 9855769.
DOI: 10.3390/bios13010104.
Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment.
He S, Zhang S, Yao Y, Xu B, Niu Z, Liao F
Front Oncol. 2022; 12:1064127.
PMID: 36568190
PMC: 9769123.
DOI: 10.3389/fonc.2022.1064127.
Differential glutamine metabolism in the tumor microenvironment - studies in diversity and heterogeneity: A mini-review.
Claiborne M, Leone R
Front Oncol. 2022; 12:1011191.
PMID: 36203456
PMC: 9531032.
DOI: 10.3389/fonc.2022.1011191.
YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration.
Li B, Wang J, Liao J, Wu M, Yuan X, Fang H
Cancer Cell Int. 2022; 22(1):287.
PMID: 36123703
PMC: 9484254.
DOI: 10.1186/s12935-022-02712-w.
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer.
Mossa F, Robesti D, Sumankalai R, Corey E, Titus M, Kang Y
Mol Cancer Res. 2022; 21(1):51-61.
PMID: 36112348
PMC: 9812897.
DOI: 10.1158/1541-7786.MCR-22-0250.
Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression.
Grima-Reyes M, Vandenberghe A, Nemazanyy I, Meola P, Paul R, Reverso-Meinietti J
Sci Adv. 2022; 8(27):eabn6491.
PMID: 35857457
PMC: 9258813.
DOI: 10.1126/sciadv.abn6491.